We also found an increase of IL-15 levels in the participants after receiving placebo, but the difference did not reach statistical significance.
← all excerpts
Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study.
1
—
—